Andlauer Healthcare Group Inc (TSX:AND)

C$ 43.25 0.14 (0.32%) Market Cap: 1.70 Bil Enterprise Value: 1.82 Bil PE Ratio: 27.37 PB Ratio: 4.21 GF Score: 90/100

Q3 2024 Andlauer Healthcare Group Inc Earnings Call Transcript
Nov 06, 2024

C$43.8 (+4.73%)

Earnings
Q2 2024 Andlauer Healthcare Group Inc Earnings Call Transcript
Aug 01, 2024

C$41.86 (+2.25%)

Earnings
Q1 2024 Andlauer Healthcare Group Inc Earnings Call Transcript
May 03, 2024

C$41.05 (-1.96%)

Earnings
Q4 2023 Andlauer Healthcare Group Inc Earnings Call Transcript
Mar 06, 2024

C$42.7 (+9.46%)

Earnings
Q3 2023 Andlauer Healthcare Group Inc Earnings Call Transcript
Nov 03, 2023

C$40.65 (+5.86%)

Earnings
Q2 2023 Andlauer Healthcare Group Inc Earnings Call Transcript
Aug 02, 2023

C$41.04 (-2.96%)

Earnings
Q1 2023 Andlauer Healthcare Group Inc Earnings Call Transcript
May 04, 2023

C$47.11 (-5.95%)

Earnings
Q4 2022 Andlauer Healthcare Group Inc Earnings Call Transcript
Mar 03, 2023

C$49.15 (+1.68%)

Earnings
Q3 2022 Andlauer Healthcare Group Inc Earnings Call Transcript
Nov 09, 2022

C$53.5 (+1.96%)

Earnings
Q2 2022 Andlauer Healthcare Group Inc Earnings Call Transcript
Aug 10, 2022

C$54 (+14.26%)

Earnings
Q1 2022 Andlauer Healthcare Group Inc Earnings Call Transcript
May 05, 2022

C$45.51 (+1.11%)

Earnings
Q3 2021 Andlauer Healthcare Group Inc Earnings Call Transcript
Nov 11, 2021

C$47.47 (-1.29%)

Earnings

Q2 2022 Andlauer Healthcare Group Inc Earnings Call Transcript

Aug 10, 2022 / 12:30PM GMT

Release Date Price: C$54 (+14.26%)

Transcript

Operator

Good morning. My name is Michelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the Andlauer Healthcare Group 2022 Second Quarter Results Conference Call.

Please be aware that certain information discussed today may be forward-looking in nature. Such forward-looking information reflects the company's current views with respect to future events. Any such information is subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those projected in the forward-looking information.

For more information on the risks, uncertainties and assumptions relating to forward-looking information please refer to the company's latest MD&A and annual information form which are available on SEDAR. Management may also refer to certain non-IFRS financial measures.

Although the company believes these measures provide useful supplemental information about financial performance they are not recognized measures and do not have standardized meanings under IFRS. Please see the company's latest MD&A

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.